Comment on: The sFlt-1 to PlGF ratio in pregnant women with rheumatoid arthritis: impact of disease activity and sulfasalazine use. Reply-Reference-Cited by-同舟云学术

Comment on: The sFlt-1 to PlGF ratio in pregnant women with rheumatoid arthritis: impact of disease activity and sulfasalazine use. Reply

Published:2021-10-22 Issue:2 Volume:61 Page:e54-e55
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Smeele Hieronymus T W¹^ORCID,Neuman Rugina I²³,Berenguer Cecile¹,Danser A H Jan²,Visser Willy²³,Dolhain Radboud J E M¹

Affiliation:

1. Department of Rheumatology

2. Department of Internal Medicine; Division of Pharmacology and Vascular Medicine

3. Department of Gynecology and Obstetrics, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands

Funder

ReumaNederland (LLP

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keab769/40820630/keab769.pdf

Reference8 articles.

1. Comment on: the sFlt-1 to PlGF ratio in pregnant women with rheumatoid arthritis: impact of disease activity and sulfasalazine use;Förger;Rheumatology (Oxford)

2. The sFlt-1 to PlGF ratio in pregnant women with rheumatoid arthritis: impact of disease activity and sulfasalazine use;Neuman;Rheumatology (Oxford),2021

3. Accurate prediction of total PlGF (Placental Growth Factor) from free PlGF and sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1): evidence for markedly elevated PlGF levels in women with acute fatty liver of pregnancy;Neuman;Hypertension,2021

4. Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat;Hewitt;Endocrinology,2006

5. Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: daily and cumulative dose;Palmsten;Pharmacoepidemiol Drug Saf,2018